Please note that during this call, we will make certain statements that may be considered forward-looking under federal securities laws, including statements related to our updated 2026 guidance. Please see yesterday's earnings release and our SEC filings, including our latest annual report on Form 10-K, for a discussion of various risks and uncertainties underlying our forward-looking statements. In addition, we discuss non-GAAP financial measures, including Core Funds from Operations or Core FFO, Adjusted Funds from Operations or AFFO, and pro forma net debt to recurring EBITDA. Reconciliations of our historical non-GAAP financial measures to the most directly comparable GAAP measures can be found at our earnings release website and SEC filings.
During the quarter, we invested nearly $425 million across our three external growth platforms while further strengthening our market-leading portfolio. The $403 million of acquisitions completed during the period represents our largest quarterly acquisition volume since 2022, as we continued to source superior risk-adjusted opportunities. During the quarter, we raised approximately $660 million of forward equity through our ATM. We now enjoy $2.3 billion of total liquidity and more than $1.6 billion of hedged capital, including a company record $1.4 billion of outstanding forward equity.
At quarter end, pro forma net debt to recurring EBITDA was just 3.2x, giving us meaningful flexibility to execute regardless of capital markets volatility. Our pipeline across all three external growth platforms is robust, yet our approach remains unchanged. We'll continue to provide updates as the year progresses, and Peter will provide additional details on our guidance and inputs shortly. Turning to our external growth activity, we had an active start to the year, leveraging our unique market positioning and deep relationships with retail partners to uncover opportunities across all three platforms.
| Metric | Period | Current guidance |
|---|---|---|
| — | — | — |
| — | — | — |
| — | — | — |
| — | — | — |
| — | — | — |
| — | — | — |
| — | — | — |
| Metric | YoY | Note |
|---|---|---|
| — | — | — |
| — | — | — |
| — | — | — |
| — | — | — |
| — | — | — |
| — | — | — |
| — | — | — |
| — | — | — |
| — | — | — |
| — | — | — |
| Topic | Previous mention | Current period | Trend |
|---|---|---|---|
| Acquisition guidance | Investment guidance had already been raised once earlier in 2026. | Investment guidance left unchanged; management deemed it inappropriate to raise it again given macro uncertainty, while describing all three platform pipelines as extremely strong and the funnel bigger than it has ever been. | — |
| Treasury stock method dilution | Prior guidance assumed approximately $0.01 of TSM dilution impact on full year AFFO per share. | Increased to an anticipated $0.02-$0.04 impact due to a higher share price and more forward equity outstanding. | — |
| Development and DFP platforms | Set an intermediate target roughly 18 months ago of approximately $250 million of development commencements in the ground per year over about three years. | Q1 was seasonally light, but development and DFP activity is expected to meaningfully ramp in Q2 and Q3, and the company is on track to potentially hit the $250 million intermediate target this year. | — |
| Pharmacy exposure | Pharmacy once exceeded 40% of the portfolio. | Pharmacy exposure down to 3.5% of annualized base rent and now outside the top 10 sectors. | — |
| Financial disclosure / supplement | No standalone financial supplement. | Published an inaugural financial supplement adding non-GAAP metrics and KPIs (recapture rate, credit and occupancy loss, same-store rent growth, tenant ownership type). | — |
| Cap rate environment | Cap rates broadly stable over the prior roughly 18-20 months. | No material change in cap rates in nearly two years despite 10-year Treasury volatility; low price-point assets (Jiffy Lube, Dutch Bros) still trade aggressively to limited 1031 buyers. | — |